 | • レポートコード：MRC308GR11603 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の血管性認知症用治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の血管性認知症用治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 血管性認知症用治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
血管性認知症用治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・治療、機器介入
用途別セグメント
・病院&診療所、リハビリテーションセンター、その他
主要な市場プレーヤー
・Eisai、Pfizer、Teva、Novartis、Apotex、Dr Reddy’s Laboratories、Sun Pharmaceutical、Hansoh Pharma、Cipla、BCG Matrix、PESTLE Analysis、SWOT Analysis、Porter’s five forces、Market Entry Strategies, Inc.、Ever Neuro Pharma GmbH、Geny Research Corp.、Johnson & Johnson
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、血管性認知症用治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血管性認知症用治療メーカーの企業概要、2019年～2022年までの血管性認知症用治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血管性認知症用治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別血管性認知症用治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの血管性認知症用治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での血管性認知症用治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および血管性認知症用治療の産業チェーンを掲載しています。
・第14、15章では、血管性認知症用治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 血管性認知症用治療の概要
– 種類別分析（2018年vs2022年vs2029年）：治療、機器介入
– 用途別分析（2018年vs2022年vs2029年）：病院&診療所、リハビリテーションセンター、その他
– 世界の血管性認知症用治療市場規模・予測
– 世界の血管性認知症用治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Eisai、Pfizer、Teva、Novartis、Apotex、Dr Reddy’s Laboratories、Sun Pharmaceutical、Hansoh Pharma、Cipla、BCG Matrix、PESTLE Analysis、SWOT Analysis、Porter’s five forces、Market Entry Strategies, Inc.、Ever Neuro Pharma GmbH、Geny Research Corp.、Johnson & Johnson
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：治療、機器介入
・用途別分析2018年-2029年：病院&診療所、リハビリテーションセンター、その他
・血管性認知症用治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・血管性認知症用治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・血管性認知症用治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・血管性認知症用治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・血管性認知症用治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Vascular Dementia Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vascular Dementia Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Medical Treatement
1.3.3 Device Intervention
1.4 Market Analysis by Application
1.4.1 Overview: Global Vascular Dementia Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Rehabilitation Centers
1.4.4 Others
1.5 Global Vascular Dementia Treatment Market Size & Forecast
1.5.1 Global Vascular Dementia Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Vascular Dementia Treatment Sales Quantity (2018-2029)
1.5.3 Global Vascular Dementia Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Eisai Details
2.1.2 Eisai Major Business
2.1.3 Eisai Vascular Dementia Treatment Product and Services
2.1.4 Eisai Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Eisai Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Vascular Dementia Treatment Product and Services
2.2.4 Pfizer Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Vascular Dementia Treatment Product and Services
2.3.4 Teva Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Vascular Dementia Treatment Product and Services
2.4.4 Novartis Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Apotex
2.5.1 Apotex Details
2.5.2 Apotex Major Business
2.5.3 Apotex Vascular Dementia Treatment Product and Services
2.5.4 Apotex Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Apotex Recent Developments/Updates
2.6 Dr Reddy’s Laboratories
2.6.1 Dr Reddy’s Laboratories Details
2.6.2 Dr Reddy’s Laboratories Major Business
2.6.3 Dr Reddy’s Laboratories Vascular Dementia Treatment Product and Services
2.6.4 Dr Reddy’s Laboratories Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dr Reddy’s Laboratories Recent Developments/Updates
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Vascular Dementia Treatment Product and Services
2.7.4 Sun Pharmaceutical Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sun Pharmaceutical Recent Developments/Updates
2.8 Hansoh Pharma
2.8.1 Hansoh Pharma Details
2.8.2 Hansoh Pharma Major Business
2.8.3 Hansoh Pharma Vascular Dementia Treatment Product and Services
2.8.4 Hansoh Pharma Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hansoh Pharma Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Vascular Dementia Treatment Product and Services
2.9.4 Cipla Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cipla Recent Developments/Updates
2.10 BCG Matrix
2.10.1 BCG Matrix Details
2.10.2 BCG Matrix Major Business
2.10.3 BCG Matrix Vascular Dementia Treatment Product and Services
2.10.4 BCG Matrix Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 BCG Matrix Recent Developments/Updates
2.11 PESTLE Analysis
2.11.1 PESTLE Analysis Details
2.11.2 PESTLE Analysis Major Business
2.11.3 PESTLE Analysis Vascular Dementia Treatment Product and Services
2.11.4 PESTLE Analysis Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PESTLE Analysis Recent Developments/Updates
2.12 SWOT Analysis
2.12.1 SWOT Analysis Details
2.12.2 SWOT Analysis Major Business
2.12.3 SWOT Analysis Vascular Dementia Treatment Product and Services
2.12.4 SWOT Analysis Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SWOT Analysis Recent Developments/Updates
2.13 Porter’s five forces
2.13.1 Porter’s five forces Details
2.13.2 Porter’s five forces Major Business
2.13.3 Porter’s five forces Vascular Dementia Treatment Product and Services
2.13.4 Porter’s five forces Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Porter’s five forces Recent Developments/Updates
2.14 Market Entry Strategies, Inc.
2.14.1 Market Entry Strategies, Inc. Details
2.14.2 Market Entry Strategies, Inc. Major Business
2.14.3 Market Entry Strategies, Inc. Vascular Dementia Treatment Product and Services
2.14.4 Market Entry Strategies, Inc. Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Market Entry Strategies, Inc. Recent Developments/Updates
2.15 Ever Neuro Pharma GmbH
2.15.1 Ever Neuro Pharma GmbH Details
2.15.2 Ever Neuro Pharma GmbH Major Business
2.15.3 Ever Neuro Pharma GmbH Vascular Dementia Treatment Product and Services
2.15.4 Ever Neuro Pharma GmbH Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Ever Neuro Pharma GmbH Recent Developments/Updates
2.16 Geny Research Corp.
2.16.1 Geny Research Corp. Details
2.16.2 Geny Research Corp. Major Business
2.16.3 Geny Research Corp. Vascular Dementia Treatment Product and Services
2.16.4 Geny Research Corp. Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Geny Research Corp. Recent Developments/Updates
2.17 Johnson & Johnson
2.17.1 Johnson & Johnson Details
2.17.2 Johnson & Johnson Major Business
2.17.3 Johnson & Johnson Vascular Dementia Treatment Product and Services
2.17.4 Johnson & Johnson Vascular Dementia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Johnson & Johnson Recent Developments/Updates
3 Competitive Environment: Vascular Dementia Treatment by Manufacturer
3.1 Global Vascular Dementia Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Vascular Dementia Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Vascular Dementia Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Vascular Dementia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Vascular Dementia Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Vascular Dementia Treatment Manufacturer Market Share in 2022
3.5 Vascular Dementia Treatment Market: Overall Company Footprint Analysis
3.5.1 Vascular Dementia Treatment Market: Region Footprint
3.5.2 Vascular Dementia Treatment Market: Company Product Type Footprint
3.5.3 Vascular Dementia Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Vascular Dementia Treatment Market Size by Region
4.1.1 Global Vascular Dementia Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Vascular Dementia Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Vascular Dementia Treatment Average Price by Region (2018-2029)
4.2 North America Vascular Dementia Treatment Consumption Value (2018-2029)
4.3 Europe Vascular Dementia Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Vascular Dementia Treatment Consumption Value (2018-2029)
4.5 South America Vascular Dementia Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Vascular Dementia Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Vascular Dementia Treatment Sales Quantity by Type (2018-2029)
5.2 Global Vascular Dementia Treatment Consumption Value by Type (2018-2029)
5.3 Global Vascular Dementia Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Vascular Dementia Treatment Sales Quantity by Application (2018-2029)
6.2 Global Vascular Dementia Treatment Consumption Value by Application (2018-2029)
6.3 Global Vascular Dementia Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Vascular Dementia Treatment Sales Quantity by Type (2018-2029)
7.2 North America Vascular Dementia Treatment Sales Quantity by Application (2018-2029)
7.3 North America Vascular Dementia Treatment Market Size by Country
7.3.1 North America Vascular Dementia Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Vascular Dementia Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Vascular Dementia Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Vascular Dementia Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Vascular Dementia Treatment Market Size by Country
8.3.1 Europe Vascular Dementia Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Vascular Dementia Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Vascular Dementia Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Vascular Dementia Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Vascular Dementia Treatment Market Size by Region
9.3.1 Asia-Pacific Vascular Dementia Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Vascular Dementia Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Vascular Dementia Treatment Sales Quantity by Type (2018-2029)
10.2 South America Vascular Dementia Treatment Sales Quantity by Application (2018-2029)
10.3 South America Vascular Dementia Treatment Market Size by Country
10.3.1 South America Vascular Dementia Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Vascular Dementia Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Vascular Dementia Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Vascular Dementia Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Vascular Dementia Treatment Market Size by Country
11.3.1 Middle East & Africa Vascular Dementia Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Vascular Dementia Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Vascular Dementia Treatment Market Drivers
12.2 Vascular Dementia Treatment Market Restraints
12.3 Vascular Dementia Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Vascular Dementia Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vascular Dementia Treatment
13.3 Vascular Dementia Treatment Production Process
13.4 Vascular Dementia Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vascular Dementia Treatment Typical Distributors
14.3 Vascular Dementia Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Vascular Dementia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Vascular Dementia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Eisai Basic Information, Manufacturing Base and Competitors
Table 4. Eisai Major Business
Table 5. Eisai Vascular Dementia Treatment Product and Services
Table 6. Eisai Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Eisai Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Vascular Dementia Treatment Product and Services
Table 11. Pfizer Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Vascular Dementia Treatment Product and Services
Table 16. Teva Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Vascular Dementia Treatment Product and Services
Table 21. Novartis Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. Apotex Basic Information, Manufacturing Base and Competitors
Table 24. Apotex Major Business
Table 25. Apotex Vascular Dementia Treatment Product and Services
Table 26. Apotex Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Apotex Recent Developments/Updates
Table 28. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 29. Dr Reddy's Laboratories Major Business
Table 30. Dr Reddy's Laboratories Vascular Dementia Treatment Product and Services
Table 31. Dr Reddy's Laboratories Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Dr Reddy's Laboratories Recent Developments/Updates
Table 33. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Major Business
Table 35. Sun Pharmaceutical Vascular Dementia Treatment Product and Services
Table 36. Sun Pharmaceutical Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sun Pharmaceutical Recent Developments/Updates
Table 38. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Hansoh Pharma Major Business
Table 40. Hansoh Pharma Vascular Dementia Treatment Product and Services
Table 41. Hansoh Pharma Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hansoh Pharma Recent Developments/Updates
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Major Business
Table 45. Cipla Vascular Dementia Treatment Product and Services
Table 46. Cipla Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cipla Recent Developments/Updates
Table 48. BCG Matrix Basic Information, Manufacturing Base and Competitors
Table 49. BCG Matrix Major Business
Table 50. BCG Matrix Vascular Dementia Treatment Product and Services
Table 51. BCG Matrix Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. BCG Matrix Recent Developments/Updates
Table 53. PESTLE Analysis Basic Information, Manufacturing Base and Competitors
Table 54. PESTLE Analysis Major Business
Table 55. PESTLE Analysis Vascular Dementia Treatment Product and Services
Table 56. PESTLE Analysis Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. PESTLE Analysis Recent Developments/Updates
Table 58. SWOT Analysis Basic Information, Manufacturing Base and Competitors
Table 59. SWOT Analysis Major Business
Table 60. SWOT Analysis Vascular Dementia Treatment Product and Services
Table 61. SWOT Analysis Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. SWOT Analysis Recent Developments/Updates
Table 63. Porter’s five forces Basic Information, Manufacturing Base and Competitors
Table 64. Porter’s five forces Major Business
Table 65. Porter’s five forces Vascular Dementia Treatment Product and Services
Table 66. Porter’s five forces Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Porter’s five forces Recent Developments/Updates
Table 68. Market Entry Strategies, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Market Entry Strategies, Inc. Major Business
Table 70. Market Entry Strategies, Inc. Vascular Dementia Treatment Product and Services
Table 71. Market Entry Strategies, Inc. Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Market Entry Strategies, Inc. Recent Developments/Updates
Table 73. Ever Neuro Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 74. Ever Neuro Pharma GmbH Major Business
Table 75. Ever Neuro Pharma GmbH Vascular Dementia Treatment Product and Services
Table 76. Ever Neuro Pharma GmbH Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Ever Neuro Pharma GmbH Recent Developments/Updates
Table 78. Geny Research Corp. Basic Information, Manufacturing Base and Competitors
Table 79. Geny Research Corp. Major Business
Table 80. Geny Research Corp. Vascular Dementia Treatment Product and Services
Table 81. Geny Research Corp. Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Geny Research Corp. Recent Developments/Updates
Table 83. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 84. Johnson & Johnson Major Business
Table 85. Johnson & Johnson Vascular Dementia Treatment Product and Services
Table 86. Johnson & Johnson Vascular Dementia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Johnson & Johnson Recent Developments/Updates
Table 88. Global Vascular Dementia Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 89. Global Vascular Dementia Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Vascular Dementia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in Vascular Dementia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Vascular Dementia Treatment Production Site of Key Manufacturer
Table 93. Vascular Dementia Treatment Market: Company Product Type Footprint
Table 94. Vascular Dementia Treatment Market: Company Product Application Footprint
Table 95. Vascular Dementia Treatment New Market Entrants and Barriers to Market Entry
Table 96. Vascular Dementia Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Vascular Dementia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 98. Global Vascular Dementia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 99. Global Vascular Dementia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Vascular Dementia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Vascular Dementia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global Vascular Dementia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global Vascular Dementia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Global Vascular Dementia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Global Vascular Dementia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Vascular Dementia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Vascular Dementia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global Vascular Dementia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global Vascular Dementia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Global Vascular Dementia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Global Vascular Dementia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Vascular Dementia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Vascular Dementia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Vascular Dementia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 115. North America Vascular Dementia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 116. North America Vascular Dementia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 117. North America Vascular Dementia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 118. North America Vascular Dementia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 119. North America Vascular Dementia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 120. North America Vascular Dementia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 121. North America Vascular Dementia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Vascular Dementia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Vascular Dementia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 124. Europe Vascular Dementia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 125. Europe Vascular Dementia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 126. Europe Vascular Dementia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 127. Europe Vascular Dementia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 128. Europe Vascular Dementia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 129. Europe Vascular Dementia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Vascular Dementia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Vascular Dementia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 132. Asia-Pacific Vascular Dementia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 133. Asia-Pacific Vascular Dementia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 134. Asia-Pacific Vascular Dementia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 135. Asia-Pacific Vascular Dementia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 136. Asia-Pacific Vascular Dementia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 137. Asia-Pacific Vascular Dementia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Vascular Dementia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Vascular Dementia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 140. South America Vascular Dementia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 141. South America Vascular Dementia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 142. South America Vascular Dementia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 143. South America Vascular Dementia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 144. South America Vascular Dementia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 145. South America Vascular Dementia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Vascular Dementia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Vascular Dementia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 148. Middle East & Africa Vascular Dementia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 149. Middle East & Africa Vascular Dementia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 150. Middle East & Africa Vascular Dementia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 151. Middle East & Africa Vascular Dementia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 152. Middle East & Africa Vascular Dementia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 153. Middle East & Africa Vascular Dementia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Vascular Dementia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Vascular Dementia Treatment Raw Material
Table 156. Key Manufacturers of Vascular Dementia Treatment Raw Materials
Table 157. Vascular Dementia Treatment Typical Distributors
Table 158. Vascular Dementia Treatment Typical Customers
List of Figures
Figure 1. Vascular Dementia Treatment Picture
Figure 2. Global Vascular Dementia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Vascular Dementia Treatment Consumption Value Market Share by Type in 2022
Figure 4. Medical Treatement Examples
Figure 5. Device Intervention Examples
Figure 6. Global Vascular Dementia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Vascular Dementia Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospitals and Clinics Examples
Figure 9. Rehabilitation Centers Examples
Figure 10. Others Examples
Figure 11. Global Vascular Dementia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Vascular Dementia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Vascular Dementia Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Vascular Dementia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Vascular Dementia Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Vascular Dementia Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Vascular Dementia Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Vascular Dementia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Vascular Dementia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Vascular Dementia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Vascular Dementia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Vascular Dementia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Vascular Dementia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Vascular Dementia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Vascular Dementia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Vascular Dementia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Vascular Dementia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Vascular Dementia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Vascular Dementia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Vascular Dementia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Vascular Dementia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Vascular Dementia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Vascular Dementia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Vascular Dementia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Vascular Dementia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Vascular Dementia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Vascular Dementia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Vascular Dementia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Vascular Dementia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Vascular Dementia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Vascular Dementia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Vascular Dementia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Vascular Dementia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Vascular Dementia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Vascular Dementia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Vascular Dementia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Vascular Dementia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Vascular Dementia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Vascular Dementia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Vascular Dementia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Vascular Dementia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Vascular Dementia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Vascular Dementia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Vascular Dementia Treatment Market Drivers
Figure 74. Vascular Dementia Treatment Market Restraints
Figure 75. Vascular Dementia Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Vascular Dementia Treatment in 2022
Figure 78. Manufacturing Process Analysis of Vascular Dementia Treatment
Figure 79. Vascular Dementia Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source